COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection(Medicine Invention Design)

Conducting an initial small, controlled clinical pharmacology trial to assess for therapeutic biologics activity (proof-of-concept) that suggests the potential for clinical benefit of COVID-19 patients.
Treat Infection of Multiple Gene Mutation COVID-19 Virus Strains.
Activate Human Antigen Presentation Reaction to COVID-19 Specific Antigen.
The human antigen presenting cells (APCs) can take up and process COVID-19 target antigen protein into small peptide fragments, and then COVID-19 virus can be killed by APCs directly.